- Previous Close
27.64 - Open
27.63 - Bid 27.40 x --
- Ask 27.41 x --
- Day's Range
27.40 - 28.23 - 52 Week Range
18.54 - 33.63 - Volume
1,250,872 - Avg. Volume
1,176,958 - Market Cap (intraday)
10.964B - Beta (5Y Monthly) 0.53
- PE Ratio (TTM)
48.95 - EPS (TTM)
0.56 - Earnings Date --
- Forward Dividend & Yield 0.24 (0.88%)
- Ex-Dividend Date Dec 12, 2024
- 1y Target Est
--
Shandong Weigao Orthopaedic Device Co., Ltd. operates as a medical device and pharmaceutical company. The company offers general consumables, such as clinical care consumables and supplies, infection protection supplies, infusion consumables, indwelling needle, anesthesia respiratory consumables, other operating room consumables, and other clinical consumables; endocrine consumables; medical informationization solutions; and orthopedics products, including spine, joint, trauma, sports medicine, orthopedics devices, bone repair materials, and spinal endoscopy products. It also provides oral treatment equipment and dental implant consumables; platelet-rich plasma therapy and negative pressure drainage consumables; and blood purification products comprising hemodialysis equipment and consumables, peritoneal dialysis preparations, and hemodialysis equipment pipeline cleaning products. In addition, the company offers pharmaceutical packaging materials, such as prefilled drug delivery system, medical packaging supplies, and automatic drug delivery system; surgical products, including surgical instruments, dressing supplies, and stoma supplies, as well as electrosurgery consumables, suture supplies, and others. Further, it provides surgical robot; whole blood collection; intervention; in vitro diagnostics; assisted reproduction; medical equipment; rehabilitation series; endoscope; and drugs, comprising injectable products, nephrology drugs, OTC drugs, and other medicines. The company was founded in 1988 and is based in Weihai, China. Shandong Weigao Orthopaedic Device Co., Ltd. operates as a subsidiary of Shandong Weigao Group Medical Polymer Co., Limited.
www.weigaoholding.com/group_list/61.htmlRecent News: 688161.SS
View MorePerformance Overview: 688161.SS
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688161.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688161.SS
View MoreValuation Measures
Market Cap
10.96B
Enterprise Value
9.16B
Trailing P/E
48.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.54
Price/Book (mrq)
2.77
Enterprise Value/Revenue
6.30
Enterprise Value/EBITDA
27.19
Financial Highlights
Profitability and Income Statement
Profit Margin
15.27%
Return on Assets (ttm)
--
Return on Equity (ttm)
5.69%
Revenue (ttm)
1.45B
Net Income Avi to Common (ttm)
221.81M
Diluted EPS (ttm)
0.56
Balance Sheet and Cash Flow
Total Cash (mrq)
2B
Total Debt/Equity (mrq)
0.17%
Levered Free Cash Flow (ttm)
--